Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
Leor Roseman, David Nutt, Robin Carhart‐Harris
Frontiers in Pharmacology (2018) Vol. 8
Open Access | Times Cited: 636

Showing 1-25 of 636 citing articles:

Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart‐Harris, Bruna Giribaldi, Rosalind Watts, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 15, pp. 1402-1411
Open Access | Times Cited: 987
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Alan K. Davis, Frederick S. Barrett, Darrick G. May, et al.
JAMA Psychiatry (2020) Vol. 78, Iss. 5, pp. 481-481
Open Access | Times Cited: 925
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Robin Carhart‐Harris, Karl Friston
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 316-344
Open Access | Times Cited: 770
Serotonin and brain function: a tale of two receptors
RL Carhart-Harris, DJ Nutt
Journal of Psychopharmacology (2017) Vol. 31, Iss. 9, pp. 1091-1120
Open Access | Times Cited: 593
Psychedelics and the essential importance of context
Robin Carhart‐Harris, Leor Roseman, Eline Haijen, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 7, pp. 725-731
Closed Access | Times Cited: 504
The entropic brain - revisited
Robin Carhart‐Harris
Neuropharmacology (2018) Vol. 142, pp. 167-178
Closed Access | Times Cited: 432
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
Michael P. Bogenschutz, Stephen Ross, Snehal Bhatt, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 10, pp. 953-953
Open Access | Times Cited: 414
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider, Katrin H. Preller
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 611-624
Closed Access | Times Cited: 406
The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects
David B. Yaden, Roland R. Griffiths
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 568-572
Open Access | Times Cited: 361
Predicting Responses to Psychedelics: A Prospective Study
Eline Haijen, Mendel Kaelen, Leor Roseman, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 317
Psychedelics, Meditation, and Self-Consciousness
Raphaël Millière, Robin Carhart‐Harris, Leor Roseman, et al.
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 305
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Leor Roseman, Eline Haijen, Kelvin Idialu-Ikato, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1076-1087
Closed Access | Times Cited: 290
Emotions and brain function are altered up to one month after a single high dose of psilocybin
Frederick S. Barrett, Manoj K. Doss, Nathan D. Sepeda, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 284
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety
Alan K. Davis, Frederick S. Barrett, Roland R. Griffiths
Journal of Contextual Behavioral Science (2019) Vol. 15, pp. 39-45
Open Access | Times Cited: 279
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
Natalie Hesselgrave, Timothy A. Troppoli, Andreas B. Wulff, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 17
Open Access | Times Cited: 259
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies
Kristoffer A. A. Andersen, Robin Carhart‐Harris, David Nutt, et al.
Acta Psychiatrica Scandinavica (2020) Vol. 143, Iss. 2, pp. 101-118
Closed Access | Times Cited: 253
Psychedelic Psychiatry’s Brave New World
David Nutt, David Erritzøe, Robin Carhart‐Harris
Cell (2020) Vol. 181, Iss. 1, pp. 24-28
Open Access | Times Cited: 250
The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects
David E. Olson
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 563-567
Open Access | Times Cited: 237
Effects of psilocybin therapy on personality structure
David Erritzøe, Leor Roseman, Matthew M. Nour, et al.
Acta Psychiatrica Scandinavica (2018) Vol. 138, Iss. 5, pp. 368-378
Open Access | Times Cited: 223
Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial
Robin von Rotz, Eva Maria Schindowski, Johannes Jungwirth, et al.
EClinicalMedicine (2022) Vol. 56, pp. 101809-101809
Open Access | Times Cited: 223
Cessation and reduction in alcohol consumption and misuse after psychedelic use
Albert Garcia‐Romeu, Alan K. Davis, Fire Erowid, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1088-1101
Closed Access | Times Cited: 222
Classical psychedelics for the treatment of depression and anxiety: A systematic review
Silvia Muttoni, Maddalena Ardissino, Christopher John
Journal of Affective Disorders (2019) Vol. 258, pp. 11-24
Closed Access | Times Cited: 216
Designer drugs: mechanism of action and adverse effects
Dino Luethi, Matthias E. Liechti
Archives of Toxicology (2020) Vol. 94, Iss. 4, pp. 1085-1133
Open Access | Times Cited: 210
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
Natasha L. Mason, Kim P. C. Kuypers, Felix Müller, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 2003-2011
Open Access | Times Cited: 202
The hidden therapist: evidence for a central role of music in psychedelic therapy
Mendel Kaelen, Bruna Giribaldi, Jordan Raine, et al.
Psychopharmacology (2018) Vol. 235, Iss. 2, pp. 505-519
Open Access | Times Cited: 199
Page 1 - Next Page

Scroll to top